Literature DB >> 11037979

CD97 isoform expression in leukocytes.

W Eichler1.   

Abstract

Different adhesive capacity in interactions with CD55 has been ascribed to the isoforms of the leukocyte CD97 antigen, CD97 (EGF 1,2,5), CD97 (EGF 1,2,3,5), and CD97 (EGF 1,2,3,4,5). In the study, coexpression of the three CD97 isoforms and predominance of CD97 (EGF 1,2,5) transcripts in leukocytes are demonstrated. The contribution of CD97 (EGF 1,2,3,5) and CD97 (EGF 1,2,3,4,5) to total CD97 levels varied among most cell types only slightly, although relatively higher mRNA levels of both isoforms were detected in U 937 cells and monocytes. In peripheral blood lymphocytes, CD97 isoforms did not show clear variation after PMA stimulation and were down-regulated equally after CD97 cross-linking. Moreover, the CD97 isoform pattern was not altered in monocytes after interferon-gamma stimulation and in synovial T cells from patients with rheumatoid arthritis. CD97 mRNA levels did not necessarily correspond to CD97 surface density. The findings suggest that adhesive activity of CD97 toward CD55 is unlikely to be regulated by differential CD97 isoform expression.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11037979

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  10 in total

1.  Expression and regulation of CD97 in colorectal carcinoma cell lines and tumor tissues.

Authors:  Matthias Steinert; Manja Wobus; Carsten Boltze; Alexander Schütz; Mandy Wahlbuhl; Jörg Hamann; Gabriela Aust
Journal:  Am J Pathol       Date:  2002-11       Impact factor: 4.307

Review 2.  Pathogenesis of Afa/Dr diffusely adhering Escherichia coli.

Authors:  Alain L Servin
Journal:  Clin Microbiol Rev       Date:  2005-04       Impact factor: 26.132

Review 3.  The Emerging Role of Adhesion GPCRs in Cancer.

Authors:  Abanoub A Gad; Nariman Balenga
Journal:  ACS Pharmacol Transl Sci       Date:  2020-01-13

4.  Effects of targeted CD97 immune epitopes small interference RNA on cellular biological behaviors in MDA-MB231 malignant breast cancer cell line.

Authors:  Hua Tian; Yang Chen; Jian-Gang Zhao; Da-Ren Liu; Wei-Hua Gong; Li Chen; Yu-Lian Wu; Jian-An Wang
Journal:  Am J Transl Res       Date:  2017-10-15       Impact factor: 4.060

5.  Detection of alternatively spliced EMR2 mRNAs in colorectal tumor cell lines but rare expression of the molecule in colorectal adenocarcinomas.

Authors:  Gabriela Aust; Jörg Hamann; Nicole Schilling; Manja Wobus
Journal:  Virchows Arch       Date:  2003-05-22       Impact factor: 4.064

6.  Afa/Dr diffusely adhering Escherichia coli infection in T84 cell monolayers induces increased neutrophil transepithelial migration, which in turn promotes cytokine-dependent upregulation of decay-accelerating factor (CD55), the receptor for Afa/Dr adhesins.

Authors:  Fréderic Bétis; Patrick Brest; Véronique Hofman; Julie Guignot; Imad Kansau; Bernard Rossi; Alain Servin; Paul Hofman
Journal:  Infect Immun       Date:  2003-04       Impact factor: 3.441

Review 7.  The EGF-TM7 family: a postgenomic view.

Authors:  Mark J Kwakkenbos; Else N Kop; Martin Stacey; Mourad Matmati; Siamon Gordon; Hsi-Hsien Lin; Jörg Hamann
Journal:  Immunogenetics       Date:  2003-11-27       Impact factor: 2.846

8.  Structural basis for CD97 recognition of the decay-accelerating factor CD55 suggests mechanosensitive activation of adhesion GPCRs.

Authors:  Minghui Niu; Shengzhao Xu; Jie Yang; Deqiang Yao; Na Li; Jie Yan; Guisheng Zhong; Gaojie Song
Journal:  J Biol Chem       Date:  2021-05-13       Impact factor: 5.157

9.  CD97/ADGRE5 Inhibits LPS Induced NF-κB Activation through PPAR-γ Upregulation in Macrophages.

Authors:  Shuai Wang; Zewei Sun; Wenting Zhao; Zhen Wang; Mingjie Wu; Yanyun Pan; Hui Yan; Jianhua Zhu
Journal:  Mediators Inflamm       Date:  2016-02-21       Impact factor: 4.711

10.  CD97 promotion of gastric carcinoma lymphatic metastasis is exosome dependent.

Authors:  Daren Liu; Chao Li; Bogusz Trojanowicz; Xiaowen Li; Dike Shi; Chenni Zhan; Zhefang Wang; Li Chen
Journal:  Gastric Cancer       Date:  2015-08-02       Impact factor: 7.370

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.